Artificial Intelligence: AI Finds Potential Drug Treatment For Rare Cancer In Children
This could herald a new era in drug discovery for other cancers.
A team of scientists, doctors, and data analysts at The Institute of Cancer Research (ICR), London, used AI to achieve a potential breakthrough in the treatment of Diffuse Intrinsic Pontine Glioma (DIPG), a rare and fast-growing type of brain tumor in children. This cancer is difficult to remove surgically because it does not have well-defined borders (is “diffuse”) and therefore, survival rates have not improved for over 50 years. (The Guardian)
BenevolentAI, a company that has built an AI drug discovery platform, proposed the initial idea for the research. Computer scientists and cancer specialists at the Royal Marsden NHS Foundation Trust also participated.
AI-proposed treatment may hit the mark
“The use of AI promises to have a transformative effect on drug discovery,” said Prof Kristian Helin, chief executive of ICR.
“In this study, use of AI has identified a drug combination which appears to have promise as a future treatment for some children with incurable brain cancer. It’s exciting to think that it could become one of the first examples of a treatment proposed by AI going on to benefit patients.”
AI finds the right drug combination
The scientists’ AI systems found that a combination of the drug everolimus with another called vandetanib could treat DIPG.
The researchers found after crunching data on existing drugs through the AI that everolimus could enhance vandetanib’s capacity to “sneak” through the blood-brain barrier and treat the cancer.
The drug regime has already been tested successfully on mice and children, and it will now go on to major clinical trials on a larger group of children.
Prof Peter Richardson, vice-president for pharmacology at BenevolentAI, said: “AI-enhanced approaches are already proving their value in expanding researchers’ capabilities to find innovative new treatment approaches – be it through uncovering new therapeutics or repurposing existing ones – not only in DIPG, but also other diseases in the future.”
Image: High-grade diffuse intrinsic pontine glioma (DIPG) in a 16-year-old female (Credit Wikimedia Commons)
Latest Alternative Investment News
Russia’s crypto mining industry is in expansion mode after China’s clampdown on its crypto miners. Also wanting to join the party are Russian oil and gas companies that flare, or…
Rossum offers an end-to-end AI document processing solution that combines its cognitive data capture platform with a full suite of integration capabilities to automate document-based communications between diverse businesses. The…
Alternative Investments/ESG: New York Life Floats ETFs For Gender Equality, Clean Oceans, Cleaner Transport
The three thematic ETFs meet investor demand for ESG approaches. IndexIQ, the New York Life Investments company, announced Wednesday the launch of three new ETFs. The IQ Engender Equality ETF…
Volante Capital, a provider of cloud payment services and financial messaging, announced Wednesday an investment of $10 million by Wells Fargo Strategic Capital. Wells Fargo joins Wavecrest Growth Partners, BNY…